1. Jackson AS, Madison . Acute hemorrhagic purpura associated with exophthalmic goiter. JAMA. 1931. 96:38–39.
2. Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE. Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med. 1997. 157:1033–1036.
3. Lee AC, Li CH, Wong LM. Childhood thrombocytopenia associated with Graves disease is distinct from idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2003. 20:39–42.
4. Sugimoto K, Sasaki M, Isobe Y, Tamayose K, Hieda M, Oshimi K. Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy. Eur J Haematol. 2005. 74:73–74.
5. Resnitzky P, Schonfeld S, Dassa H. Effect of Graves' disease on idiopathic thrombocytopenic purpura. Arch Int Med. 1979. 139:483–484.
8. Hymes K, Blum M, Lackner H, Karpatkin S. Easy brusing, thrombocytopenia and elevated platelet immunoglobulin G in Graves' disease and Hashimoto' thyroiditis. Ann intern Med. 1981. 94:27–30.
9. Mahoney CP, Pyne GE, Stamm SJ, Bakke JL. Neonatal Graves' disease. Am J Dis Child. 1964. 107:516–522.
10. Adrouny A, Sandler RM, Carmel R. Variable presentation of thrombocytopenia in Graves' disease. Arch Int Med. 1982. 142:1460–1464.
11. Kurata Y, Nishioeda Y, Tsubakio T, Kitani T. Thrombocytopenic in Graves' disease: Effect of T3 on platelet kinetics. Acta Haematol. 1980. 63:185–190.
12. Panzer S, Haubenstock A, Minar E. Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab. 1990. 70:491–496.
13. Bizzaro N. Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am J Hematol. 1992. 39:294–298.
14. Volpe R. Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte immunocyte signaling : a review. Thyroid. 1994. 4:217–223.
15. Weetman AP. The immunomodulatory effects of antithyroid drugs. Thyroid. 1994. 4:145–146.
16. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000. 37:239–248.
17. Berchtold P, Muller D, Beardsley D, Fujisawa K, Kaplan C, Kekomaki R, Lipp E, Morell-Kopp MC, Kiefel V, McMillan R, von dem Borne AE, Imbach P. International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. Br J Haematol. 1997. 96:477–483.
18. Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci. 1998. 19:237–244.
19. Kroll H, Sun QH, Santoso S. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood. 2000. 96:1409–1414.
20. Richard AF, Edward FE, Zimmerman SL. Acute thrombocytopenic purpura associated with administration of propylthiouracil. JAMA. 1950. 143:1089–1892.